UFGROUP SHARES-FRAN - cancer drug

The drug was developed over 10 years ago Preclinical studies completed. The first and second phase clinical trials have been completed. Winner of the Second World Congress of Immunopathology - 2004. Winner of the 4th international conference on immunotherapy - 2008. 8 patents in the field of human immunity. The scientific invention is valued at over USD 3 billion - 2010. The size of the market is over USD 150 billion. Investments Investments in a promising business with a turnover exceeding USD 200 billion per year Opportunity Access to 'FRAN' medicine at the lowest price for the project investor dividends The first dividend for investors is planned for 2020 https://ufgroup.pro/lk?ref=536